Alberto Carlos Reino: Anticoagulation in Membranous Nephropathy – Albumin Is Not Enough
Alberto Carlos Reino, Nephrologist at Nefron SAS, shared on LinkedIn:
”Anticoagulation in Membranous Nephropathy: Albumin Is Not Enough
Yes, membranous nephropathy carries a high thrombotic risk — but serum albumin alone should not drive anticoagulation decisions.
A validated decision-analysis tool integrates both thrombotic and bleeding risk, incorporating age, kidney function, haemoglobin, bleeding history, dialysis status, and an explicit benefit–risk threshold (VTE prevented per major bleed).
This allows individualised, patient-centred decisions, rather than reflex anticoagulation.
According to KDIGO, prophylactic anticoagulation is reasonable only in patients with severe hypoalbuminemia and low bleeding risk.
Aspirin remains an option when bleeding risk is high.
Despite their popularity, DOACs remain insufficiently studied in nephrotic syndrome, where heavy proteinuria may alter both safety and efficacy.
Bottom line:
In MN, anticoagulation should be risk-stratified, evidence-based, and individualised — not protocol-driven.”
Find the Decision Analysis here.
Stay updated with Hemostasis Today.
-
Jul 9, 2026, 12:16Fernanda Betti Solano: Could Iron Deficiency Be Affecting Your Sleep?
-
Jul 9, 2026, 12:08Andreas Calatzis: What is the Rationale for Collagen-Induced Platelet Aggregation Testing?
-
Jul 9, 2026, 11:54Deepak Pradhan։ Can Withaferin-A Help Combat Drug-Resistant Malaria?
-
Jul 9, 2026, 11:26Peter Zhang: Is Canada Ready for the Gene Therapy Era?
-
Jul 9, 2026, 09:35Pradeebha Muthukumar: Do You Know the Signs of Anemia?
-
Jul 9, 2026, 09:24Maryam Majid: Machine Learning for Anemia Risk Prediction
-
Jul 9, 2026, 08:46Jordan Agay: Folate Deficiency in Patients Receiving PARP Inhibitors
-
Jul 9, 2026, 08:29Laura Katz: Is Human Lactoferrin Better Than Bovine Lactoferrin?
-
Jul 9, 2026, 08:17Anziya Sabeer: AI-Driven Non-Invasive Anemia Detection